ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 492 out of 2094

$447K Total Retail Price of All Prescriptions

Rank: 586 out of 2094

361 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 5,731 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 239 210 1 1
FUROSEMIDE 215 205 2 6
LEVOTHYROXINE SODIUM 181 137 3 3
HYDROCODONE-ACETAMINOPHEN 179 136 S3 4 42
AMLODIPINE BESYLATE 161 155 5 2
ATORVASTATIN CALCIUM 153 150 6 5
HYDROCHLOROTHIAZIDE 146 142 7 12
SERTRALINE HCL 137 126 8 26
NEXIUM 121 118 9 16
AMLODIPINE BESYLATE-BENAZEPRIL 119 114 10 58
METOPROLOL SUCCINATE 119 115 10 9
METOPROLOL TARTRATE 96 72 12 10
LISINOPRIL 94 77 13 7
ALLOPURINOL 86 82 14 50
DONEPEZIL HCL 86 86 14 20
PROAIR HFA 82 80 16 45
LOSARTAN POTASSIUM 75 75 17 17
ZOLPIDEM TARTRATE 72 60 18 14
OMEPRAZOLE 70 65 19 4
LIPITOR 62 61 20 39
PREDNISONE 61 60 21 54
METFORMIN HCL 59 58 22 8
DIOVAN 58 54 23 13
CLOPIDOGREL 58 55 23 22
FAMOTIDINE 57 45 25 34
ATENOLOL 56 56 26 21
CEFUROXIME 56 52 26 137
PANTOPRAZOLE SODIUM 55 35 28 37
TRAMADOL HCL 55 32 28 33
GLIMEPIRIDE 54 50 30 31
BENAZEPRIL HCL 52 52 31 154
SYNTHROID 52 49 31 44
JANUVIA 51 44 33 35
PRADAXA 50 50 34 209
SPIRONOLACTONE 50 38 34 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.